C2C12-Luc

C2C12 Luciferase Cell Line engineered for stable, high-efficiency expression of the luciferase gene.This advanced tool delivers exceptionally high imaging quality and precise, quantifiable luminescence, ensuring your data is both robust and publication-ready.
Designed for versatility, the C2C12 Luciferase Cell Line seamlessly adapts to a broad spectrum of applications—from promoter activity assays and mammalian two-hybrid studies to sophisticated in vivo imaging.
C2C12 cell line is a subclone of a mouse myoblast cell line established by D. Yaffe and O. Saxel; this cell line differentiate rapidly, forming contractile myotubes and producing characteristic myosin. Treating C2C12 cells with bone morphogenetic protein 2 (BMP-2) leads to a switch in the differentiation pathway of C2C12 cells from myoblasts to osteoblasts. Tests have shown that C2C12 cells are negative for limb girdle developmental malformation virus (murine pox).